Member Info for Rufiji

The expectation of the first quarter of 2017 is Harry's wish rather than reality. It would seem no interest at all from the commercial side and we are relying on development banks. Not only are they slow but they have a focus on the transfer of.social and.financial benefits to the locals. Nothing wrong.in that but how long to negotiate !? Working capital needs are.going to add.pressure to funding

Gold is looking very weak. Apart from the short lived Trump spike it is making a series of lowerand lower highs. The technical analysts see 1240 as crucial and if it cannot hold that level we could be looking at 1200 and below. Worrying to see that one or two big holders of gold have liquidated their positions in the metal and rising bond yields are not helping

Hi Ironic In your calculations who picks up the refining costs for the gold. The mines will not be delivering pure gold. They deliver DORE which is about 90% -95% gold and various other usually metals. These latter have to be refined away to get to marketable gold. There is refining capability in Dubai but there are also.costs involved.

At sometime undoubtedly, but there are still some.trends.to support the growth storey imo Rapid growth of bespoke gin and vodka brands/ production, improved distribution and.availability, growing overseas presence.most notably in Germany, this year's weather, growing brand acceptance and customer purchasing criteria,etc. Guess it will be down to the guidance

According to technical analysts, 1260 was a key support level at the 200 day moving average. It better get back above 1260 very soon or else the long term uptrend could be broken. If so, 1200 might be nearer than 1400.

Yes, the trading update/ guidance will be pivotal more so than the actual interim results. This has to support progress on.gold.trading and hopefully that the top line will likely surprise on the upside. Happy to give the company the benefit of the doubt For now, but they could certainly prove.their PR treatment.of PIs

Maybe, but for me the key issue will be the guidance if any surrounding the interim results, which if last year is any.guide should be released within the next couple of weeks. This has to be positive given that the funding raised should be working trading vole upwards.

Possibly but the 2016 interim results could be equally interesting. They were released the end of August last year so imminent. I want to see top line progress.

Your efforts to show an estimate of future earnings are appreciated, but I doubt there is as much " blue sky" as you claim. The business plan comments in the RNS were very thin to say the least. 1 Gold trading in Dubai has to a large extent been driven by tax policy in India where the imposition of VAT on gold trades has driven much of the market offshore to Dubai. Should this policy be reversed, and there is strong lobbying for it to be so although I am not saying it will happen, then a lot of trading will go back on-shore to India 2. Indian purchases of gold have been under pressure in recent months as the high price dissuades gold purchases that are traditional around Hindi weddings. 3 The barriers to entry to gold trading do not seem that high, and the appearance of well-capitalised competitors cannot be discounted. As it is , competitive intensity is quite high. 4 It follows that margins could well come under pressure 5. WSBN do seem to have reasonable product throughput from South America but I would like to see progress in securing more. I remain positive about WSBN and have not sold any of my holding but am certainly less gung ho than some . 2 p would suit me fine

We have not been dealt any favours by the problems at Valeant and the short interest.attached thereto. I have not paid too much attention to the " most shorted stock" list lately but would not be surprised if biotech stocks are well represented. Still US indices have pushed higher in today's session so perhaps some recovery tomorrow. But overall a case of take the pricing or leave it !!

Some chatter on Bloomberg that the biotech sector is under stress and.increased volatility/risk could see the no of IPOs pulled.back.Market liquidity also said to be tight. It all seems market related rather than stock specific but some positive announcement wouldhelp

Agree and if they are good they should give momentum to the IPO. Suppose they could work in the other direction if they fail to meet expectations but expectations do seem positive

Depends on market conditions in the New Year.and appetite of investors. My point is that the IPO market in the US is struggling at present not helped by liquidity challenges. Agree the price action suggests "no problem" but that is not to say that will be the outcome. Bye the bye I am not saying the IPO will not.happen just that there may have to be some stretch in the timetable.

The IPO market in the US has had a dreadful year, and while biotech has performed better than other sectors prices are well below their peaks earlier in 2015. There must be the chance that the IPO could be delayed till later on the year, but even if it goes ahead I would be wary of over-optimistic expectations. While the long term story remains intact the speed.by which the.company gets there could be reduced